# Warfarin

## Cofarin 1mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                       |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OCOF1                                                                                                                                                                                                                                                                      |
| 適應症     | Treatment & prophylaxis of thromboembolic disorders.                                                                                                                                                                                                                       |
| 用法用量   | Initial dose as 2-5mg once daily, depends on patient's PT/INR. Maintenance dose would be 2-10mg, adjusted by patient's PT/INR. Duration of the treatment should be kept until the risks have been excluded.                                                                |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                 |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                               |
| 禁忌       | Severe hepatic or renal disease, actual or potential haemorrhagic conditions, severe hypertension, endocarditis, ulceration of the GI & urinary tract, visceral carcinoma, endocarditis, neurosurgery, recent surgery on the eye, brain or spinal cord. Pregnancy.         |
| 副作用     | Alopecia, skin rashes of various kinds, hemorrhagic skin necrosis. Cardiovascular: Cholesterol embolus syndrome Dermatologic: Tissue necrosis Hematologic: Hemorrhage Immunologic: Hypersensitivity reaction (infrequent ) Ophthalmic: Intraocular hemorrhage (5% to 11% ) |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                    |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                        |

## COFARIN 5mg

##### 

| 標題       | 說明                                                                                                                                                                                                                                                                       |
|:-----------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 藥品代碼   | OCOF5                                                                                                                                                                                                                                                                      |
| 適應症     | Treatment & prophylaxis of thromboembolic disorders.                                                                                                                                                                                                                       |
| 用法用量   | Initial dose as 2-5mg once daily, depends on patient's PT/INR. Maintenance dose would be 2-10mg, adjusted by patient's PT/INR. Duration of the treatment should be kept until the risks have been excluded.                                                                |
| 肝功能異常 | 需調整劑量                                                                                                                                                                                                                                                                 |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                               |
| 禁忌       | Severe hepatic or renal disease, actual or potential haemorrhagic conditions, severe hypertension, endocarditis, ulceration of the GI & urinary tract, visceral carcinoma, endocarditis, neurosurgery, recent surgery on the eye, brain or spinal cord. Pregnancy.         |
| 副作用     | Alopecia, skin rashes of various kinds, hemorrhagic skin necrosis. Cardiovascular: Cholesterol embolus syndrome Dermatologic: Tissue necrosis Hematologic: Hemorrhage Immunologic: Hypersensitivity reaction (infrequent ) Ophthalmic: Intraocular hemorrhage (5% to 11% ) |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                    |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                        |

